论文部分内容阅读
诱导性多能干细胞(i PSC)为下一代医学提供了激动人心的光明前景。自从2006年京都大学山中伸弥的研究团队诱导出这种细胞,京都大学i PS细胞研究和应用中心(Ci RA)就一直在推进i PSC技术的发展和相关研究。2015年,Ci RA与武田制药公司达成大规模合作,建立了武田-Ci RA联合研发项目(T-Ci RA)。为此,Ci RA主任山中伸弥接受《自然》杂志专访,畅谈T-Ci RA项目的意义及
Induced pluripotent stem cells (i PSC) provide an exciting bright future for next generation medicine. Since the team of Shinya Yamanaka of Kyoto University induced such cells in 2006, Kyoto University’s i PS Cell Research and Applications Center (Ci RA) has been pushing the development of i PSC technology and related research. In 2015, Ci RA and Takeda Pharmaceutical Co. reached a large-scale cooperation to establish Takeda-Ci RA Joint Research and Development Project (T-Ci RA). To this end, Ci RA Director Yamanaka Yamanaka interview with “Nature” magazine, talk about the significance of the T-Ci RA project and